Redcare Pharmacy NV
XETRA:RDC

Watchlist Manager
Redcare Pharmacy NV Logo
Redcare Pharmacy NV
XETRA:RDC
Watchlist
Price: 92 EUR 1.77% Market Closed
Market Cap: 1.9B EUR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

RDC Price Targets Summary
Redcare Pharmacy NV

Wall Street analysts forecast RDC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RDC is 170.09 EUR with a low forecast of 94.94 EUR and a high forecast of 224.7 EUR.

RDC Lowest Forecast
Wall Street Target
94.94 EUR
3% Upside
RDC Average Forecast
Wall Street Target
170.09 EUR
85% Upside
RDC Highest Forecast
Wall Street Target
224.7 EUR
144% Upside
Lowest
Price Target
94.94 EUR
3% Upside
Average
Price Target
170.09 EUR
85% Upside
Highest
Price Target
224.7 EUR
144% Upside
Redcare Pharmacy NV Competitors:
Price Targets
4164
Al Nahdi Medical Company SCJSC
7% Upside
3349
Cosmos Pharmaceutical Corp
5% Upside
4163
Al-Dawaa Medical Services Co
24% Upside
FRAGUAB
Corporativo Fragua SAB de CV
138% Upside
4164
Al Nahdi Medical Company SCJSC
7% Upside
3349
Cosmos Pharmaceutical Corp
5% Upside
4163
Al-Dawaa Medical Services Co
24% Upside
FRAGUAB
Corporativo Fragua SAB de CV
138% Upside
RADL3
Raia Drogasil SA
55% Upside
3088
MatsukiyoCocokara & Co
6% Upside
3341
Nihon Chouzai Co Ltd
54% Downside
S
7649
Sugi Holdings Co Ltd
5% Upside

Revenue
Forecast

Revenue Estimate
Redcare Pharmacy NV

For the last 8 years the compound annual growth rate for Redcare Pharmacy NV's revenue is 38%. The projected CAGR for the next 3 years is 22%.

38%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Redcare Pharmacy NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
19%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Redcare Pharmacy NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss
What are analyst estimates?

See Also

Summary
RDC intrinsic value, competitors valuation, and company profile.
DCF Valuation
RDC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RDC stock valuation using valuation multiples.
Wall Street Estimates
RDC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RDC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RDC's stock price target?
Price Target
170.09 EUR

According to Wall Street analysts, the average 1-year price target for RDC is 170.09 EUR with a low forecast of 94.94 EUR and a high forecast of 224.7 EUR.

What is Redcare Pharmacy NV's Revenue forecast?
Projected CAGR
22%

For the last 8 years the compound annual growth rate for Redcare Pharmacy NV's revenue is 38%. The projected CAGR for the next 3 years is 22%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.